Amicus Therapeutics Total Assets 2007-2020 | FOLD

Amicus Therapeutics total assets from 2007 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Amicus Therapeutics Annual Total Assets
(Millions of US $)
2019 $850
2018 $790
2017 $627
2016 $1,037
2015 $908
2014 $210
2013 $128
2012 $110
2011 $70
2010 $113
2009 $85
2008 $129
2007 $167
2006 $60
2005 $0
Amicus Therapeutics Quarterly Total Assets
(Millions of US $)
2020-06-30 $701
2020-03-31 $738
2019-12-31 $850
2019-09-30 $882
2019-06-30 $918
2019-03-31 $765
2018-12-31 $790
2018-09-30 $839
2018-06-30 $826
2018-03-31 $870
2017-12-31 $627
2017-09-30 $681
2017-06-30 $939
2017-03-31 $993
2016-12-31 $1,037
2016-09-30 $918
2016-06-30 $914
2016-03-31 $863
2015-12-31 $908
2015-09-30 $987
2015-06-30 $404
2015-03-31 $193
2014-12-31 $210
2014-09-30 $125
2014-06-30 $118
2014-03-31 $112
2013-12-31 $128
2013-09-30 $69
2013-06-30 $82
2013-03-31 $93
2012-12-31 $110
2012-09-30 $118
2012-06-30 $112
2012-03-31 $121
2011-12-31 $70
2011-09-30 $79
2011-06-30 $90
2011-03-31 $103
2010-12-31 $113
2010-09-30 $64
2010-06-30 $75
2010-03-31 $88
2009-12-31 $85
2009-09-30 $99
2009-06-30 $109
2009-03-31 $116
2008-12-31 $129
2008-09-30 $143
2008-06-30 $151
2008-03-31 $160
2007-12-31 $167
2007-09-30 $125
2007-06-30 $132
2007-03-31 $0
2006-09-30 $0
2006-06-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.899B $0.182B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.910B 10.23
Amgen (AMGN) United States $130.879B 14.22
CSL (CSLLY) Australia $94.333B 0.00
Gilead Sciences (GILD) United States $75.236B 10.83
Regeneron Pharmaceuticals (REGN) United States $61.976B 23.70
Vertex Pharmaceuticals (VRTX) United States $55.269B 30.84
Illumina (ILMN) United States $46.974B 54.63
Biogen (BIIB) United States $39.286B 6.98
Seattle Genetics (SGEN) United States $34.263B 0.00
Moderna (MRNA) United States $27.885B 0.00
BeiGene (BGNE) Cayman Islands $27.328B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.301B 10.96
Genmab (GMAB) Denmark $22.905B 14.45
Genmab (GNMSF) Denmark $21.446B 4.94
Exact Sciences (EXAS) United States $19.690B 0.00
Incyte (INCY) United States $19.322B 0.00
BioNTech SE (BNTX) Germany $18.995B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Horizon Therapeutics Public (HZNP) Ireland $16.135B 37.75
Alnylam Pharmaceuticals (ALNY) United States $14.707B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.815B 100.24
ARGENX SE-ADR (ARGX) Netherlands $12.167B 0.00
MyoKardia (MYOK) United States $11.815B 0.00
QIAGEN (QGEN) Netherlands $11.388B 25.64
Guardant Health (GH) United States $11.105B 0.00
Sarepta Therapeutics (SRPT) United States $10.961B 0.00
Bio-Techne Corp (TECH) United States $10.264B 70.42
Mirati Therapeutics (MRTX) United States $9.316B 0.00
Repligen (RGEN) United States $9.232B 146.53
Ascendis Pharma (ASND) Denmark $8.679B 0.00
Galapagos (GLPG) Belgium $8.365B 30.26
ACADIA Pharmaceuticals (ACAD) United States $7.310B 0.00
Adaptive Biotechnologies (ADPT) United States $6.955B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.885B 213.30
Exelixis (EXEL) United States $6.690B 24.33
Acceleron Pharma (XLRN) United States $6.496B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.904B 0.00
Blueprint Medicines (BPMC) United States $5.809B 0.00
Novavax (NVAX) United States $5.490B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.454B 14.90
Arena Pharmaceuticals (ARNA) United States $5.023B 0.00
Emergent Biosolutions (EBS) United States $5.022B 19.89
Denali Therapeutics (DNLI) United States $4.863B 0.00
China Biologic Products (CBPO) China $4.575B 27.15
NeoGenomics (NEO) United States $4.555B 1375.00
Vir Biotechnology (VIR) United States $4.514B 0.00
Fate Therapeutics (FATE) United States $4.122B 0.00
Halozyme Therapeutics (HALO) United States $4.082B 0.00
Reata Pharmaceuticals (RETA) United States $4.001B 0.00
Twist Bioscience (TWST) United States $3.733B 0.00
Insmed (INSM) United States $3.676B 0.00
Legend Biotech (LEGN) United States $3.605B 0.00
Bluebird Bio (BLUE) United States $3.558B 0.00
Global Blood Therapeutics (GBT) United States $3.472B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.439B 0.00
MorphoSys AG (MOR) Germany $3.381B 44.31
Eidos Therapeutics (EIDX) United States $2.830B 0.00
Alkermes (ALKS) Ireland $2.530B 53.03
PHARMA MAR SA (PHMMF) Spain $2.396B 0.00
I-Mab (IMAB) China $2.349B 0.00
Seres Therapeutics (MCRB) United States $2.304B 0.00
Editas Medicine (EDIT) United States $2.024B 0.00
Sorrento Therapeutics (SRNE) United States $2.018B 0.00
Beam Therapeutics (BEAM) United States $1.980B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.968B 0.00
Amarin (AMRN) Ireland $1.889B 0.00
Zymeworks (ZYME) Canada $1.885B 0.00
UniQure (QURE) Netherlands $1.875B 0.00
Inovio Pharmaceuticals (INO) United States $1.861B 0.00
Viela Bio (VIE) United States $1.822B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Revance Therapeutics (RVNC) United States $1.716B 0.00
Intra-Cellular Therapies (ITCI) United States $1.617B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.581B 0.00
Sangamo Therapeutics (SGMO) United States $1.578B 0.00
Intellia Therapeutics (NTLA) United States $1.494B 0.00
Zealand Pharma (ZEAL) Denmark $1.435B 0.00
Ligand Pharmaceuticals (LGND) United States $1.386B 46.84
Arcus Biosciences (RCUS) United States $1.346B 0.00
Epizyme (EPZM) United States $1.315B 0.00
Alcobra (ARCT) United States $1.287B 0.00
Mersana Therapeutics (MRSN) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.274B 7.43
Mesoblast (MESO) Australia $1.265B 0.00
Zealand Pharma (ZLDPF) Denmark $1.264B 0.00
NGM Biopharmaceuticals (NGM) United States $1.200B 0.00
Cytokineticsorporated (CYTK) United States $1.151B 0.00
REGENXBIO (RGNX) United States $1.111B 0.00
Retrophin (RTRX) United States $1.095B 0.00
Myriad Genetics (MYGN) United States $1.079B 0.00
Heska (HSKA) United States $1.060B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.043B 0.00
Genetron Holdings (GTH) China $1.029B 0.00
Castle Biosciences (CSTL) United States $1.009B 0.00
Adverum Biotechnologies (ADVM) United States $0.982B 0.00
Compugen (CGEN) Israel $0.957B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.954B 0.00
Athenex (ATNX) United States $0.930B 0.00
Vericel (VCEL) United States $0.920B 0.00
Northwest Biotherapeutics (NWBO) United States $0.909B 0.00
NantKwest (NK) United States $0.902B 0.00
Scholar Rock Holding (SRRK) United States $0.897B 0.00
Codexis (CDXS) United States $0.851B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.841B 0.00
Morphic Holding (MORF) United States $0.822B 0.00
Arvinas (ARVN) United States $0.806B 0.00
Alector (ALEC) United States $0.789B 0.00
Pliant Therapeutics (PLRX) United States $0.785B 0.00
Intrexon (PGEN) United States $0.767B 0.00
AnaptysBio (ANAB) United States $0.763B 0.00
Frequency Therapeutics (FREQ) United States $0.756B 0.00
Protagonist Therapeutics (PTGX) United States $0.746B 0.00
Cellectis S.A (CLLS) France $0.741B 0.00
Agenus (AGEN) United States $0.704B 0.00
Pharming Group (PHGUF) Netherlands $0.688B 15.71
Syndax Pharmaceuticals (SNDX) United States $0.688B 0.00
MiMedx (MDXG) United States $0.648B 0.00
Cara Therapeutics (CARA) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.622B 0.00
Celldex Therapeutics (CLDX) United States $0.620B 0.00
Kadmon Holdings (KDMN) United States $0.596B 0.00
VBI Vaccines (VBIV) United States $0.580B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.579B 5.07
Geron (GERN) United States $0.574B 0.00
IVERIC Bio (ISEE) United States $0.558B 0.00
Cel-Sci (CVM) United States $0.516B 0.00
MeiraGTx Holdings (MGTX) United States $0.510B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.493B 0.00
Albireo Pharma (ALBO) United States $0.489B 0.00
Anika Therapeutics (ANIK) United States $0.489B 21.37
AMAG Pharmaceuticals (AMAG) United States $0.473B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.472B 0.00
UROGEN PHARMA (URGN) United States $0.472B 0.00
Clovis Oncology (CLVS) United States $0.466B 0.00
Prothena (PRTA) Ireland $0.459B 0.00
MannKind (MNKD) United States $0.458B 0.00
Sutro Biopharma (STRO) United States $0.455B 0.00
Avid Bioservices (CDMO) United States $0.443B 0.00
Amryt Pharma (AMYT) United Kingdom $0.441B 0.00
Dynavax Technologies (DVAX) United States $0.424B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.417B 0.00
Starpharma Holdings (SPHRY) Australia $0.411B 0.00
Merus (MRUS) Netherlands $0.385B 0.00
Forte Biosciences (FBRX) United States $0.380B 0.00
Puma Biotechnology (PBYI) United States $0.377B 0.00
Cardiff Oncology (CRDF) United States $0.358B 0.00
Cue Biopharma (CUE) United States $0.356B 0.00
Cellular Biomedicine (CBMG) United States $0.355B 0.00
AC Immune SA (ACIU) Switzerland $0.354B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.352B 0.00
Kala Pharmaceuticals (KALA) United States $0.352B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.350B 0.00
Spero Therapeutics (SPRO) United States $0.349B 0.00
IBio (IBIO) United States $0.346B 0.00
ANI Pharmaceuticals (ANIP) United States $0.342B 8.08
Kamada (KMDA) Israel $0.339B 16.21
Precision BioSciences (DTIL) United States $0.338B 0.00
Trevena (TRVN) United States $0.334B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.333B 0.00
Innate Pharma S.A (IPHA) France $0.329B 0.00
BioDelivery Sciences (BDSI) United States $0.327B 23.14
Syros Pharmaceuticals (SYRS) United States $0.320B 0.00
Athersys (ATHX) United States $0.320B 0.00
Selecta Biosciences (SELB) United States $0.317B 0.00
CytomX Therapeutics (CTMX) United States $0.306B 0.00
ChromaDex (CDXC) United States $0.298B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.287B 0.00
WAVE Life Sciences (WVE) Singapore $0.287B 0.00
NextCure (NXTC) United States $0.284B 0.00
XOMA (XOMA) United States $0.263B 0.00
PDL BioPharma (PDLI) United States $0.254B 0.00
Affimed (AFMD) Germany $0.252B 0.00
Pluristem Therapeutics (PSTI) Israel $0.249B 0.00
Arbutus Biopharma (ABUS) United States $0.234B 0.00
TELA Bio (TELA) United States $0.233B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.218B 0.00
Fortress Biotech (FBIO) United States $0.214B 0.00
Dyadic (DYAI) United States $0.211B 0.00
Verastem (VSTM) United States $0.210B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
Eton Pharmaceuticals (ETON) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
ADMA Biologics Inc (ADMA) United States $0.184B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.177B 0.00
CorMedix Inc (CRMD) United States $0.169B 0.00
Liquidia Technologies (LQDA) United States $0.161B 0.00
Cerecor (CERC) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.160B 0.00
DBV Technologies S.A (DBVT) France $0.159B 0.00
Theratechnologies (THTX) Canada $0.155B 0.00
Kindred Biosciences (KIN) United States $0.155B 0.00
Bellus Health (BLU) Canada $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.151B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.147B 0.00
Checkpoint Therapeutics (CKPT) United States $0.146B 0.00
GENFIT S.A (GNFT) France $0.145B 0.00
VolitionRX (VNRX) United States $0.144B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.141B 6.60
Aptinyx (APTX) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Exicure (XCUR) United States $0.138B 0.00
Unum Therapeutics (COGT) United States $0.136B 0.00
Prometic Life Sciences (LMNL) Canada $0.131B 0.00
SESEN BIO, INC (SESN) United States $0.130B 0.00
AquaBounty Technologies (AQB) United States $0.129B 0.00
Cidara Therapeutics (CDTX) United States $0.125B 0.00
Aytu Bioscience (AYTU) United States $0.124B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Gritstone Oncology (GRTS) United States $0.112B 0.00
Strongbridge Biopharma (SBBP) United States $0.108B 0.00
Celyad SA (CYAD) Belgium $0.105B 0.00
Orgenesis (ORGS) United States $0.103B 5.26
Abeona Therapeutics (ABEO) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
Oncobiologics (OTLK) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Enzo Biochem (ENZ) United States $0.092B 0.00
Idera Pharmaceuticals (IDRA) United States $0.090B 0.00
Palatin Technologies (PTN) United States $0.090B 0.00
Cyclerion Therapeutics (CYCN) United States $0.085B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.084B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Evogene (EVGN) Israel $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) United States $0.079B 75.81
Bionano Genomics (BNGO) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.069B 0.00
Adocia (ADOCY) France $0.067B 0.00
Synlogic (SYBX) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Curis (CRIS) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Appili Therapeutics (APLIF) Canada $0.061B 0.00
AmpliPhi Biosciences (ARMP) United States $0.059B 0.00
Edesa Biotech (EDSA) Canada $0.058B 0.00
TRACON Pharmaceuticals (TCON) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.055B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.054B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Cocrystal Pharma (COCP) United States $0.044B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Novogen (KZIA) Australia $0.042B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Pulmatrix (PULM) United States $0.038B 0.00
Vaccinex (VCNX) United States $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Cleveland BioLabs (CBLI) United States $0.035B 0.00
Apricus Biosciences (SEEL) United States $0.035B 0.00
ATyr Pharma (LIFE) United States $0.032B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
OvaScience (MLND) United States $0.029B 0.00
Advaxis (ADXS) United States $0.026B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00